GO:0004064 arylesterase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004064 arylesterase activity is a molecular function defined as the catalysis of the reaction: a phenyl acetate + H2O = a phenol + acetate.
• The term is synonymous with A-esterase activity, aromatic esterase, aryl-ester hydrolase, and paraoxonase activity.
• Paraoxonase-1 (PON1) is the prototypical enzyme carrying arylesterase activity, and its arylesterase activity is widely measured in human serum [1, 2, 3].
• Arylesterase activity is associated with cardiovascular disease, diabetes, chronic kidney disease, autism spectrum disorders, and mortality in hemodialysis patients [1, 2, 4, 5, 6].
• Arylesterase activity can be modulated by exercise and is influenced by PON1 phenotype, but activity and concentration are not always correlated [7, 8].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal testing of genes encoding arylesterase enzymes and their regulators.
Description
Arylesterase activity (GO:0004064) is a molecular function that catalyzes the hydrolysis of phenyl acetate to phenol and acetate. This activity is attributed to enzymes such as paraoxonase-1 (PON1), which also exhibits lactonase and paraoxonase activities [1, 2]. The arylesterase activity of PON1 is commonly measured in serum and has been linked to oxidative stress and lipid metabolism [3, 4]. Because of its role in detoxifying oxidized lipids and its association with multiple diseases, arylesterase activity is a subject of intense clinical and biochemical research [1, 5, 6]. Understanding its mechanism, regulation, and genetic determinants is essential for developing therapeutic and diagnostic strategies.
arylesterase activity At A Glance
| GO ID | GO:0004064 |
|---|---|
| GO term | arylesterase activity |
| Ontology | molecular_function |
| Synonym | A-esterase activity, aromatic esterase, aryl-ester hydrolase, paraoxonase activity |
| Definition | Catalysis of the reaction: a phenyl acetate + H2O = a phenol + acetate. |
| Major function | Hydrolysis of aromatic esters, including detoxification of organophosphates and oxidized lipids. |
| Representative enzyme | Paraoxonase-1 (PON1) |
| Associated diseases | Coronary artery disease, type 1 diabetes, chronic kidney disease, autism spectrum disorders, cervical intraepithelial neoplasia. |
| Research relevance | Biomarker of oxidative stress and cardiovascular risk; target for gene editing studies. |
What Is GO:0004064?
Arylesterase activity (GO:0004064) is defined as the catalysis of the reaction: a phenyl acetate + H2O = a phenol + acetate. In other words, it is an enzymatic activity that hydrolyzes aromatic esters, such as phenyl acetate, into their corresponding phenol and acetate. This activity is also known by synonyms including A-esterase activity, aromatic esterase, aryl-ester hydrolase, and paraoxonase activity.
Why Is arylesterase activity Important in Cell Biology?
Arylesterase activity is important because it reflects the functional status of enzymes like PON1, which protect against oxidative stress and cardiovascular disease. Altered arylesterase activity has been reported in patients with coronary artery disease, type 1 diabetes, chronic kidney disease, autism spectrum disorders, and cervical intraepithelial neoplasia [1, 2, 3, 4, 5]. Moreover, low arylesterase activity is associated with increased all-cause mortality in maintenance hemodialysis patients. Therefore, measuring and understanding arylesterase activity has diagnostic, prognostic, and therapeutic implications.
• Arylesterase activity is a biomarker of PON1 function and oxidative stress status [1, 3].
• Reduced arylesterase activity is associated with coronary artery disease.
• Arylesterase activity is altered in children with type 1 diabetes mellitus and correlates with oxidative stress.
• Low arylesterase activity is linked to chronic kidney disease in type 2 diabetes.
• Decreased serum arylesterase activity is observed in autism spectrum disorders.
• Arylesterase activity predicts all-cause mortality in maintenance hemodialysis patients.
• Exercise can modulate arylesterase activity, dissociating activity from PON1 concentration.
• Arylesterase phenotype influences the association between arylesterase and cholinesterase activities.
• Arylesterase activity is a potential target for therapeutic modulation in cardiovascular and metabolic diseases.
• CRISPR-based editing of PON1 and related genes can help establish causality in disease models.
Molecular Mechanism of arylesterase activity
Substrate Binding and Catalysis
In simple terms: The enzyme grabs a phenyl acetate molecule and breaks it apart using water.
Arylesterase activity catalyzes the hydrolysis of phenyl acetate to phenol and acetate. The enzyme binds the aromatic ester substrate and facilitates nucleophilic attack by water, leading to cleavage of the ester bond. This reaction is characteristic of PON1, which exhibits arylesterase activity toward phenyl acetate [1, 2].
Enzyme Structure and Active Site
In simple terms: The enzyme has a special pocket where the chemical reaction happens.
PON1, the prototypical arylesterase, is a calcium-dependent enzyme with a six-bladed beta-propeller structure. Its active site contains a catalytic dyad and requires calcium ions for stability and activity. The arylesterase activity resides in this active site, which also accommodates lactone and organophosphate substrates [3, 4].
Cofactors and Regulation
In simple terms: Calcium helps the enzyme work, and its levels can change with health status.
Arylesterase activity of PON1 is calcium-dependent. The enzyme's activity can be modulated by oxidative stress, inflammation, and lifestyle factors such as exercise. Additionally, arylesterase activity may be influenced by genetic polymorphisms in the PON1 gene, leading to different phenotypes.
Physiological Role
In simple terms: This enzyme helps protect the body from harmful chemicals and oxidized fats.
Arylesterase activity contributes to the detoxification of organophosphate compounds and the hydrolysis of oxidized lipids, thereby protecting against oxidative damage. This function links arylesterase activity to cardiovascular health, diabetes, and other oxidative stress-related conditions [1, 2, 6].
Key Genes Involved in GO:0004064 arylesterase activity
The following genes and proteins are directly or indirectly associated with arylesterase activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PON1 | Paraoxonase-1, primary enzyme with arylesterase activity | Biomarker in cardiovascular disease, diabetes, and oxidative stress [1, 2, 3] |
| PON2 | Paraoxonase-2, related enzyme with antioxidant properties | Potential role in cellular oxidative stress defense |
| PON3 | Paraoxonase-3, associated with HDL and lactonase activity | May contribute to arylesterase-like activities |
| APOA1 | Major HDL apolipoprotein, interacts with PON1 | Influences PON1 stability and activity |
| CETP | Cholesteryl ester transfer protein, modulates HDL composition | Affects PON1 activity and HDL function |
| LCAT | Lecithin-cholesterol acyltransferase, HDL remodeling | Indirectly affects arylesterase activity |
| SOD1 | Superoxide dismutase 1, antioxidant enzyme | Oxidative stress modifies arylesterase activity |
| CAT | Catalase, antioxidant enzyme | Correlates with arylesterase activity in oxidative stress |
| GPX1 | Glutathione peroxidase 1, antioxidant enzyme | Modulates oxidative stress and PON1 activity |
| NQO1 | NAD(P)H quinone dehydrogenase 1, antioxidant enzyme | Potential link to arylesterase activity |
| TNF | Tumor necrosis factor, inflammatory cytokine | Inflammation reduces PON1 arylesterase activity |
| IL6 | Interleukin-6, inflammatory cytokine | Negative correlation with arylesterase activity |
| CRP | C-reactive protein, inflammation marker | Inversely associated with arylesterase activity |
| ADIPOQ | Adiponectin, metabolic regulator | May influence PON1 activity |
| PPARG | Peroxisome proliferator-activated receptor gamma | Regulates genes involved in lipid metabolism and PON1 |
| NRF2 | Nuclear factor erythroid 2-related factor 2, antioxidant regulator | May regulate PON1 expression |
| BCHE | Butyrylcholinesterase, related esterase | Arylesterase phenotype correlates with cholinesterase activity |
How Is arylesterase activity Regulated?
Arylesterase activity is regulated at multiple levels. PON1 expression and activity can be modulated by oxidative stress, inflammatory cytokines, and metabolic factors. Exercise has been shown to affect arylesterase activity independently of PON1 concentration. Genetic polymorphisms in the PON1 promoter and coding regions influence enzyme levels and activity, leading to distinct arylesterase phenotypes. Additionally, calcium availability is essential for PON1 stability and catalytic function.
arylesterase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PON1 | Coronary artery disease | PON1 knockout or overexpression in mouse models |
| PON1 | Type 1 diabetes mellitus | PON1 point mutation knock-in in diabetic mouse models |
| PON1 | Chronic kidney disease | PON1 knockout in type 2 diabetes mouse models |
| PON1 | Autism spectrum disorders | PON1 overexpression in neuronal cell models |
| PON1 | Cervical intraepithelial neoplasia | PON1 knockdown in cervical cancer cell lines |
Cardiovascular Disease
A meta-analysis of patients with coronary artery disease found that PON1 arylesterase activity levels were significantly lower in cases compared to controls, suggesting that reduced arylesterase activity is associated with increased cardiovascular risk.
Diabetes and Metabolic Disorders
In children with type 1 diabetes mellitus, arylesterase activity of PON1 correlates with oxidative stress markers, indicating a role in diabetes-related oxidative damage. In type 2 diabetes, arylesterase activity but not PCSK9 levels is associated with chronic kidney disease.
Neurological and Other Conditions
Decreased serum arylesterase activity has been reported in autism spectrum disorders, suggesting a link between arylesterase function and neurodevelopmental conditions. In cervical intraepithelial neoplasia, PON1 arylesterase activity and oxidative stress parameters are altered.
Mortality in Hemodialysis
In maintenance hemodialysis patients, lower serum paraoxonase/arylesterase activity is associated with increased all-cause mortality, highlighting its prognostic value.
From arylesterase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PON1 arylesterase activity protect against atherosclerosis? | PON1 knockout mouse |
| How do PON1 polymorphisms affect enzyme activity? | PON1 point mutation knock-in mouse |
| Can PON1 overexpression reduce oxidative stress? | PON1 transgenic overexpression mouse |
| What is the role of PON1 in diabetes-related kidney disease? | PON1 knockout in diabetic mouse |
| Does PON1 arylesterase activity modulate neuronal function? | PON1 knockout or overexpression in neuronal cells |
| Can CRISPR activation of PON1 increase arylesterase activity? | CRISPRa in hepatocyte cell lines |
How to Study the arylesterase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phenyl acetate hydrolysis assay | Arylesterase activity | Clinical biomarker studies |
| Genotyping (PCR-RFLP) | PON1 polymorphisms | Association with disease risk |
| CRISPR knockout | Gene function | Causal testing in cell models |
| CRISPR knock-in | Specific mutations | Modeling human polymorphisms |
| Western blot | PON1 protein levels | Correlation with activity |
| ELISA | PON1 concentration | Large cohort studies |
| qRT-PCR | PON1 mRNA expression | Transcriptional regulation studies |
Enzymatic Activity Assays
Arylesterase activity is typically measured spectrophotometrically using phenyl acetate as substrate, monitoring the formation of phenol at 270 nm. This assay is widely used in clinical studies to assess PON1 function [1, 2, 3].
Genetic and Genomic Approaches
Genotyping of PON1 polymorphisms (e.g., Q192R, L55M) helps determine arylesterase phenotypes. CRISPR-based editing can create isogenic cell lines with specific mutations to study their impact on activity.
Oxidative Stress Biomarkers
Arylesterase activity is often correlated with oxidative stress markers such as malondialdehyde, total antioxidant status, and antioxidant enzyme activities (e.g., SOD, CAT) to understand its role in disease [2, 3].
Proteomic and Expression Analysis
Western blotting and ELISA can quantify PON1 protein levels, while qPCR measures mRNA expression. These methods help distinguish between changes in activity and concentration.
How CRISPR Can Be Used to Study GO:0004064 arylesterase activity
Knockout
CRISPR knockout of PON1 in cell lines or animal models can abolish arylesterase activity, allowing researchers to test its role in oxidative stress, lipid metabolism, and disease progression.
Point Mutation
Introducing point mutations (e.g., Q192R) into the PON1 gene via CRISPR can mimic human polymorphisms and reveal their effects on arylesterase activity and substrate specificity.
Knock-in
Knock-in of tagged PON1 (e.g., FLAG or GFP) enables tracking of enzyme localization and interaction partners while preserving arylesterase activity.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of PON1 can increase arylesterase activity, providing a gain-of-function model to study protective effects against oxidative damage.
How EDITGENE Supports arylesterase activity Research
Researchers studying arylesterase activity-related genes often need to determine whether a candidate gene is causally involved in enzyme function, disease risk, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional validation of genes such as PON1 and its regulators.
Contact EDITGENE today to design your custom CRISPR model for arylesterase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PON1 Knockout HEK293 Cell Line | EDJ-KQ513 | Human | 5444 | Details Get a Quote |
| APMAP Knockout HEK293 Cell Line | EDJ-KQ1957 | Human | 57136 | Details Get a Quote |
| PON2 Knockout HEK293 Cell Line | EDJ-KQ2477 | Human | 5445 | Details Get a Quote |
| CA1 Knockout HEK293 Cell Line | EDJ-KQ4174 | Human | 759 | Details Get a Quote |
| CA2 Knockout HEK293 Cell Line | EDJ-KQ4175 | Human | 760 | Details Get a Quote |
| PON3 Knockout HEK293 Cell Line | EDJ-KQ5505 | Human | 5446 | Details Get a Quote |
| PON1 Knockout A-549 Cell Line | EDJ-KQ20184 | Human | 5444 | Details Get a Quote |
| PON2 Knockout A-549 Cell Line | EDJ-KQ23046 | Human | 5445 | Details Get a Quote |
| PON2 Knockout HCT 116 Cell Line | EDJ-KQ23047 | Human | 5445 | Details Get a Quote |
| PON2 Knockout HeLa Cell Line | EDJ-KQ23048 | Human | 5445 | Details Get a Quote |
| APMAP Knockout A-549 Cell Line | EDJ-KQ21911 | Human | 57136 | Details Get a Quote |
| APMAP Knockout HCT 116 Cell Line | EDJ-KQ21912 | Human | 57136 | Details Get a Quote |
| APMAP Knockout HeLa Cell Line | EDJ-KQ21913 | Human | 57136 | Details Get a Quote |
| CA2 Knockout A-549 Cell Line | EDJ-KQ26615 | Human | 760 | Details Get a Quote |
| CA2 Knockout HCT 116 Cell Line | EDJ-KQ26616 | Human | 760 | Details Get a Quote |
Displaying Records 1 To 15 Of 24 Records
Frequently Asked Questions About arylesterase activity
What is arylesterase activity?
Arylesterase activity (GO:0004064) is a molecular function that catalyzes the hydrolysis of phenyl acetate to phenol and acetate. It is commonly associated with the enzyme paraoxonase-1 (PON1) [1, 2].
What genes are involved in arylesterase activity?
The primary gene is PON1, which encodes paraoxonase-1. Other related genes include PON2, PON3, and genes influencing oxidative stress such as SOD1 and CAT [1, 2, 3].
How is arylesterase activity measured?
It is typically measured using a spectrophotometric assay with phenyl acetate as substrate, monitoring phenol formation at 270 nm [1, 2].
What diseases are associated with arylesterase activity?
Altered arylesterase activity is associated with coronary artery disease, type 1 diabetes, chronic kidney disease, autism spectrum disorders, and cervical intraepithelial neoplasia [1, 2, 3, 4, 5].
Can exercise affect arylesterase activity?
Yes, exercise repetitions can modulate arylesterase activity of PON1 in plasma, and this effect can be dissociated from changes in PON1 concentration.
What is the relationship between arylesterase activity and oxidative stress?
Arylesterase activity is inversely correlated with oxidative stress markers, as it detoxifies oxidized lipids and organophosphates [2, 3].
Is arylesterase activity the same as paraoxonase activity?
Paraoxonase activity is a synonym for arylesterase activity (GO:0004064), but PON1 also exhibits lactonase activity, which is distinct [1, 2].
How can CRISPR be used to study arylesterase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to test the causal role of PON1 and related genes in arylesterase activity and disease.
What is the clinical significance of low arylesterase activity?
Low arylesterase activity is associated with increased cardiovascular risk and all-cause mortality in hemodialysis patients [1, 6].
Are there genetic polymorphisms that affect arylesterase activity?
Yes, polymorphisms in the PON1 gene, such as Q192R and L55M, influence arylesterase activity and phenotype.
Conclusion
Arylesterase activity (GO:0004064) is a critical molecular function with broad implications for human health, particularly in cardiovascular disease, diabetes, and oxidative stress-related conditions. PON1 is the primary enzyme responsible for this activity, and its measurement serves as a valuable biomarker. CRISPR-based models offer powerful tools to dissect the genetic and mechanistic basis of arylesterase activity, paving the way for targeted therapeutic interventions.
References
- 1. Zuin M et al.. 2022. Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis.. Dis Markers 2022:4264314 PMID: 35308142
- 2. Diaa Subhi M et al.. 2024. Evaluation of Paraoxonase-1 Activity of Arylesterase and Lactonase and Their Correlation with Oxidative Stress in Children with Type 1 Diabetes Mellitus.. Rep Biochem Mol Biol 13(3):301-309 PMID: 40330569
- 3. Butorac D et al.. 2024. Paraoxonase and arylesterase activity of paraoxonase 1 and oxidative stress parameters in cervical intraepithelial neoplasia.. Biochem Med (Zagreb) 34(1):030701 PMID: 38125616
- 4. Didas N et al.. 2020. Arylesterase activity but not PCSK9 levels is associated with chronic kidney disease in type 2 diabetes.. Int Urol Nephrol 52(9):1725-1732 PMID: 32661629
- 5. Gaita L et al.. 2010. Decreased serum arylesterase activity in autism spectrum disorders.. Psychiatry Res 180(2-3):105-13 PMID: 20488557
- 6. Suematsu Y et al.. 2019. Association of Serum Paraoxonase/Arylesterase Activity With All-Cause Mortality in Maintenance Hemodialysis Patients.. J Clin Endocrinol Metab 104(10):4848-4856 PMID: 30920627
- 7. Otocka-Kmiecik A et al.. 2023. Effect of Exercise Repetitions on Arylesterase Activity of PON1 in Plasma of Average-Trained Men-The Dissociation between Activity and Concentration.. Antioxidants (Basel) 12(6) PMID: 37372026
- 8. Aoki Y et al.. 2014. Arylesterase phenotype-specific positive association between arylesterase activity and cholinesterase specific activity in human serum.. Int J Environ Res Public Health 11(2):1422-43 PMID: 24473115
